Cencora (NYSE:COR – Get Free Report) posted its earnings results on Wednesday. The company reported $3.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.18 by $0.16, Briefing.com reports. The firm had revenue of $74.20 billion for the quarter, compared to analysts’ expectations of $73.32 billion. Cencora had a return on equity of 266.60% and a net margin of 0.65%. The business’s revenue was up 10.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.92 earnings per share. Cencora updated its FY 2024 guidance to 13.550-13.650 EPS and its FY24 guidance to $13.55-$13.65 EPS.
Cencora Stock Up 1.3 %
Shares of Cencora stock traded up $3.11 during trading on Friday, reaching $247.57. The company’s stock had a trading volume of 3,292,432 shares, compared to its average volume of 1,217,035. The company has a 50-day simple moving average of $228.85 and a two-hundred day simple moving average of $231.18. Cencora has a 1-year low of $171.65 and a 1-year high of $247.66. The company has a quick ratio of 0.53, a current ratio of 0.89 and a debt-to-equity ratio of 3.93. The company has a market cap of $49.38 billion, a price-to-earnings ratio of 27.08, a P/E/G ratio of 1.68 and a beta of 0.45.
Cencora Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 26th. Stockholders of record on Friday, August 9th will be given a $0.51 dividend. The ex-dividend date of this dividend is Friday, August 9th. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.82%. Cencora’s payout ratio is 22.32%.
Insiders Place Their Bets
Analyst Upgrades and Downgrades
COR has been the topic of a number of research analyst reports. StockNews.com raised Cencora from a “buy” rating to a “strong-buy” rating in a report on Friday. Citigroup upped their price target on Cencora from $265.00 to $280.00 and gave the stock a “buy” rating in a research report on Tuesday, April 30th. Wells Fargo & Company increased their target price on Cencora from $236.00 to $249.00 and gave the stock an “equal weight” rating in a research report on Thursday. SVB Leerink reissued an “outperform” rating and set a $275.00 price target on shares of Cencora in a research note on Thursday, June 27th. Finally, Robert W. Baird raised their price objective on Cencora from $285.00 to $287.00 and gave the company an “outperform” rating in a research note on Thursday. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $243.00.
Cencora Company Profile
Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
See Also
- Five stocks we like better than Cencora
- How to Use the MarketBeat Dividend Calculator
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Energy and Oil Stocks Explained
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Cencora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cencora and related companies with MarketBeat.com's FREE daily email newsletter.